Cargando…
TREM2 acts as a tumor suppressor in hepatocellular carcinoma by targeting the PI3K/Akt/β-catenin pathway
Triggering receptor expressed on myeloid cells 2 (TREM2) is involved in nonmalignant pathological processes. However, TREM2’s function in malignant diseases, especially in hepatocellular carcinoma (HCC) remains unknown. In the present study, we report that TREM2 is a novel tumor suppressor in HCC. T...
Autores principales: | Tang, Wenqing, Lv, Bei, Yang, Biwei, Chen, Yukai, Yuan, Feifei, Ma, Lijie, Chen, She, Zhang, Si, Xia, Jinglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350080/ https://www.ncbi.nlm.nih.gov/pubmed/30683932 http://dx.doi.org/10.1038/s41389-018-0115-x |
Ejemplares similares
-
TREM2 Acts as a Tumor Suppressor in Colorectal Carcinoma through Wnt1/β-catenin and Erk Signaling
por: Kim, Su-Man, et al.
Publicado: (2019) -
Protein convertase subtilisin/Kexin type 9 inhibits hepatocellular carcinoma growth by interacting with GSTP1 and suppressing the JNK signaling pathway
por: He, Mingyan, et al.
Publicado: (2022) -
Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma
por: Yang, Biwei, et al.
Publicado: (2018) -
MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling
por: Shen, Qiushuo, et al.
Publicado: (2022) -
Cadherin Related Family Member 2 Acts As A Tumor Suppressor By Inactivating AKT In Human Hepatocellular Carcinoma
por: Xia, Ziyuan, et al.
Publicado: (2019)